Description:
AZD3759 is a n orally available inhibitor of the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon oral administration, AZD3759 binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR.
- Molecular Weight:459.91
- Purity:98%
Molecular Formula:
C22H23ClFN5O3
Canonical SMILES:
O=C(N1[C@H](C)CN(C)CC1)OC2=CC3=C(NC4=CC=CC(Cl)=C4F)N=CN=C3C=C2OC
Solubility:
Soluble in DMSO, not in water
Appearance:
Solid powder
Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Synonyms:
AZD3759; AZD-3759; AZD 3759. Weitere Informationen finden Sie
hier